Wealth Quarterback’s ImmuCell ICCC Stock Holding History

Wealth Quarterback’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-95	Closed	-$360	–	403
2020 Q1	$360	Buy	+95	New	+$468	﹤0.01%	908

Other funds holding ICCC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OMC

Overbrook Management Corp New York $529M AUM 31.5% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SRC

Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wealth Quarterback's ICCC Position: Q2 2020 in Review

Wealth Quarterback sold out of ImmuCell (ICCC) in Q2 2020, closing a stake of 95 shares — an estimated $360 sold.

Wealth Quarterback first reported a position in ICCC in Q1 2020 and held it in 1 quarter. The position peaked at $360 in Q1 2020. 24 funds tracked by Wall St. Rank hold ICCC as of Q2 2020.

Wealth Quarterback reported no remaining ImmuCell position as of Q2 2020 after selling out during the quarter.
Wealth Quarterback sold 95 ImmuCell shares in Q2 2020, an estimated $360.
Wealth Quarterback first reported a position in ImmuCell in Q1 2020 and held it in 1 quarter.
Wealth Quarterback's ImmuCell position peaked at $360 in Q1 2020.
24 funds tracked by Wall St. Rank held ImmuCell as of Q2 2020.

Based on Wealth Quarterback's 13F filing for Q2 2020, filed 17 Aug 2020.